Original paper
Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial
Abstract
Fibroadenoma (FA) is the most common benign solid breast mass in women, with no definite method of management. Because fibroadenoma is dependent on female sex hormones and comprises hypertrophic changes at cellular levels, we investigated the effects of metformin (MF), a safe hypoglycemic agent with anti-estrogenic and anti-proliferative properties, in the management of fibroadenoma.In this randomized clinical trial study, eligible women with...
Paper Details
Title
Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial
Published Date
Aug 20, 2021
Journal
Volume
21
Issue
1
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History